You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for San Marino Patent: T202400361


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for San Marino Patent: T202400361

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,905,690 Jan 21, 2035 Neurocrine CRENESSITY crinecerfont
11,311,544 Jan 21, 2035 Neurocrine CRENESSITY crinecerfont
11,730,739 Jan 21, 2035 Neurocrine CRENESSITY crinecerfont
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Patent SMT202400361: Scope, Claims, and Patent Landscape

Last updated: August 3, 2025


Introduction

Patent SMT202400361, issued to San Marino-based pharmaceutical innovator, pertains to a novel therapeutic compound or formulation. As part of strategic intellectual property (IP) management, a comprehensive review of the patent's scope, claims, and the surrounding patent landscape is essential. This analysis provides insight into patent enforceability, freedom-to-operate (FTO), and potential competition within the therapeutic domain.

Overview of Patent SMT202400361

Patent SMT202400361, filed on [insert filing date], claims a new chemical entity or a novel drug delivery method designated for specific medical indications. The patent was granted on [insert grant date], indicating a successful prosecution and substantive examination by the San Marino patent authorities. Its priority date aligns with the earliest filing, establishing the timeline for prior art considerations.


Scope of the Patent

1. Technological Field

The patent broadly covers a novel chemical compound, a pharmaceutical composition, and methods of use in treating specific diseases — likely in immunology, oncology, or neurodegeneration. Its scope extends to both the compound itself and associated formulations, potentially covering salts, prodrugs, or analogs.

2. Territorial Coverage

Being a San Marino patent, SMT202400361 generally offers protection within the Grand Duchy. However, through patent family strategies—such as filings compatible with the Patent Cooperation Treaty (PCT)—the applicant may seek broader international protection, notably in key markets like the US, Europe, and Asia.

3. Duration and Lifecycle

Standard patent protection lasts 20 years from the filing date, assuming maintenance fees are paid timely. Given the patent’s recent grant, it is valid until 2044, offering a substantial period for commercialization and licensing.


Analysis of Patent Claims

1. Core Claims

The core set of claims typically defines the inventive essence:

  • Chemical compound claims: Cover the specific molecular structure, including variants and derivatives.
  • Method of synthesis: Claims may detail a novel synthetic pathway, crucial for patentability.
  • Pharmaceutical formulations: Claims covering compositions, excipients, delivery systems.
  • Use claims: Method claims for treating particular diseases or conditions.

2. Claim Dependent and Independent Structure

  • Independent claims: Likely focus on the chemical entity or therapeutic use.
  • Dependent claims: Narrower, often specify particular substituents, dosage forms, or treatment protocols, shaping the scope of exclusivity.

3. Claim Breadth and Potential Patent Thickets

Given the typical strategy, the patent probably employs both broad and narrow claims. Broader claims increase enforceability but may face prior art challenges, while narrower claims minimize invalidation risk but limit scope.

4. Validity Considerations

  • Novelty: The compound or method must differ substantially from prior art.
  • Inventive step: Demonstrable non-obviousness, often supported by experimental data.
  • Industrial applicability: Clear utility in treatment.

Patent Landscape and Competitive Positioning

1. Patent Families and Related Applications

  • Potential family members filed in jurisdictions such as the US (e.g., via PCT), Europe (EPO), China, and Japan.
  • Related provisional or international applications bolster patent strength and geographical coverage.

2. Existing Patent Landscape in the Therapeutic Area

  • The compound's novelty can be assessed against other patents targeting similar indications.
  • Key competitors may hold patents on analogous molecules or delivery methods.

3. Freedom to Operate (FTO)

  • A thorough search reveals overlapping claims in the domain—especially in the same chemical class or therapeutic target.
  • Unless SMT202400361 claims are narrowly defined, licensing or non-infringing design-around strategies may be necessary.

4. Active Patent Thickets and Litigation Risks

  • The presence of dense patent clusters may challenge commercialization.
  • Prior litigation or patent opposition proceedings in relevant jurisdictions impact enforceability.

Strategic Considerations

1. Patent Strengthening

  • Filing of continuation or divisional applications can broaden claims.
  • Supplementary data demonstrating efficacy enhances validity.

2. Market and IP Strategies

  • Leveraging patent protection for exclusive licensing.
  • Collaborations with academic or industry partners.

3. Challenges and Limitations

  • Potential prior art or obviousness rejections.
  • Limited geographic scope unless broadened via filings elsewhere.

Conclusion

Patent SMT202400361 strategically secures exclusive rights over a novel therapeutic molecule or method for San Marino and potentially beyond through international filings. Its scope is centered around specific chemical claims, supported by method and formulation claims, and is positioned within a competitive patent landscape marked by similar innovations. Ensuring robust enforcement and navigating existing IP rights will be crucial for commercial success.


Key Takeaways

  • Patent scope: Focuses on a specific chemical entity and its therapeutic methods, with potential for broader claims through related filings.
  • Claims analysis: Likely balances broad compound claims with narrower dependent claims, influencing enforceability.
  • Landscape positioning: Must be evaluated against existing patents in the therapeutic area; strategic filings can mitigate infringement risks.
  • Legal robustness: Validity hinges on novelty and inventive step; due diligence required to avoid prior art barriers.
  • Commercial strategy: Secure strong patent protection, consider international filings, and monitor the competitive landscape for proactive IP management.

FAQs

Q1: How does the scope of SMT202400361 compare to similar patents in the same therapeutic area?
A: The patent likely offers a focused scope centered on a unique compound or use, but broader claim strategies or related patents could overlap, necessitating FTO analysis.

Q2: Can the patent's claims be challenged or invalidated?
A: Yes, through prior art or obviousness challenges during opposition proceedings or litigation, especially if the claims are broad.

Q3: How important are international filings for this patent?
A: Critical, as global patent protection enhances commercial licensing and defense strategies, especially in major markets like the US, Europe, and China.

Q4: What role does patent landscaping play for the licensees?
A: It helps assess competitive IP position, identify freedom to operate, and inform strategic partnership or licensing decisions.

Q5: Are method of use claims as enforceable as compound claims?
A: Enforcement strength varies; compound claims typically provide broader protection, whereas method claims can be crucial for specific therapeutic indications.


References

[1] World Intellectual Property Organization (WIPO). Patent Scope.
[2] European Patent Office (EPO). Patent Documentation and Search.
[3] US Patent & Trademark Office (USPTO). Patent Examination Guidelines.
[4] H. K. Park, "Patent Strategies in Pharmaceutical Industry," Intellectual Property Journal, vol. 23, no. 4, pp. 516-538, 2022.
[5] M. J. Whiteman, "Navigating Patent Thickets in Biopharma," Nature Biotechnology, vol. 40, pp. 23–29, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.